Cervical antibody responses to a herpes simplex virus type 2 glycoprotein subunit vaccine

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 1-7

  Ashley, Rhoda L ^a   Crisostomo, Flor Mari ^b   Doss, Michael ^b   Sekulovich, Rose E ^b   Burke, Rae Lyn ^b   Shaughnessy, Mary ^b   Corey, Lawrence ^b   Polissar, Nayak L ^b   Langenberg, Andria G M ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS GLYCOPROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; SECRETION; SERODIAGNOSIS; UTERINE CERVIX; VACCINATION;

EID: 0031820299     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515611     Document Type: Article

References (20)

1. Corey L, Wald A. New developments in the biology of genital herpes. In: Sacks SL, Straus SE, Whitley RJ, Griffiths PD, eds. Clinical management of herpes viruses. Washington, DC: IOS Press, 1995:43-53.
2. Schmidt OW, Fife KH, Corey L. Reinfection is an uncommon occurrence in patients with symptomatic recurrent genital herpes. J Infect Dis 1984;149:645-6.
3. Mertz GJ, Benedetti J, Ashley R, Selke S, Corey L. Risk factors for sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202
4. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
5. Ashley RL, Corey L, Dalessio J, et al. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections J Infect Dis 1994;170:20-6.
6. Ashley R, Wald A, Corey L. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic response after genital HSV-2 infection. J Virol 1994;68:5284-6.
7. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 1988;26:662-7.
8. Dalessio J, Ashley R. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J Clin Microbiol 1992;30:1005-7.
9. Langenberg AGM, Burke RL, Adair SF, et al. A recombinant glycoprotein vaccine for herpes simplex type 2: safety and immunogenicity Ann Intern Med 1995;122:889-98.
10. Cerasaro M, Nicotra M, Coghi IM, Stampone L, Amodei M, Dondero F. Detection of antispermatozoal iso-antibodies in cervical mucus from infertile and fertile women using the Shulman-Hekman capillary test Immunol Factors Hum Reprod 1982;51-7.
11. Hocini H, Barra A, Belec L, et al. Systemic and secretory humoral immunity in the normal human vaginal tract. Scand J Immunol 1995;42-269-74.
12. Lu XS, Belec L, Pillot J. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J Infect Dis 1993;167:1189-92.
13. Bouvet JP, Belec L, Pires R, Pillot J. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect Immun 1994;62:3957-61.
14. Bjercke S, Brandtzaeg P. Glandular distribution of immunoglobulins J chain, secretory component, and HLA-DR in the human endometrium throughout the menstrual cycle. Hum Reprod 1993;8:1420-5.
15. Kutteh WH, Hatch KD, Blackwell RE, Mestecky J. Secretory immune system of the female reproductive tract. I. Immunoglobulin and secretory component-containing cells. Obstet Gynecol 1988;71:56-60
16. Wagner DK, Clements ML, Reimer CB, Snyder MH, Nelson DL, Murphy BR. Analysis of IgG antibody responses after live and inactivated influenza A vaccine indicate that nasal wash IgG is a transudate from serum J Clin Microbiol 1987;25:559-62.
17. Wang JB, Adler SP, Hempfling S, et al. Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus. J Infect Dis 1996;174:387-92.
18. Bélec L, Dupré T, Prazuck T, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local responses in HIV infection. J Infect Dis 1995;172:691-7.
19. Whaley KJ, Zeitlin L, Barratt RA, Hoen TE, Cone RA. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J Infect Dis 1994;169:647-9.
20. Robbins JB, Schneerson R, Szu SC. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis 1995;171:1387-98.